GOSSAMER BIO INC (GOSS) Institutional Ownership Changes & 13F Activity
GOSSAMER BIO INC (GOSS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Nea Management Company, Llc, Octagon Capital Advisors Lp, Arch Venture Management, Llc, Samsara Biocapital, Llc, and 683 Capital Management, Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Neuberger Berman Group Llc | Buy | +12,558 | — | 12,558 | $38.93K | Q4 2025 | Oct 27, 2026 |
| Cornerstone Financial Management Llc | Buy | +282 | — | 282 | $874.00 | Q4 2025 | Aug 28, 2026 |
| Algert Global Llc | Buy | +332,336 | — | 332,336 | $1.03M | Q4 2025 | Aug 11, 2026 |
| Corient Private Wealth Llc | Buy | +3,845,885 | — | 3,845,885 | $11.92M | Q4 2025 | Feb 19, 2026 |
| Mackenzie Financial Corp | Buy | +306,453 | — | 306,453 | $954.25K | Q4 2025 | Feb 18, 2026 |
| Mercer Global Advisors Inc | Buy | +23,983 | — | 23,983 | $74.35K | Q4 2025 | Feb 18, 2026 |
| Beacon Pointe Advisors, Llc | Buy | +11,000 | — | 11,000 | $34.10K | Q4 2025 | Feb 18, 2026 |
| Nea Management Company, Llc | Buy | +18,093,034 | — | 18,093,034 | $56.09M | Q4 2025 | Feb 17, 2026 |
| Octagon Capital Advisors Lp | Buy | +13,915,371 | — | 13,915,371 | $43.14M | Q4 2025 | Feb 17, 2026 |
| Arch Venture Management, Llc | Buy | +8,055,916 | — | 8,055,916 | $24.97M | Q4 2025 | Feb 17, 2026 |
| Samsara Biocapital, Llc | Buy | +7,222,559 | — | 7,222,559 | $22.39M | Q4 2025 | Feb 17, 2026 |
| 683 Capital Management, Llc | Buy | +5,190,800 | — | 5,190,800 | $16.09M | Q4 2025 | Feb 17, 2026 |
| Hhlr Advisors, Ltd. | Buy | +4,974,041 | — | 4,974,041 | $15.42M | Q4 2025 | Feb 17, 2026 |
| Palo Alto Investors Lp | Buy | +4,471,592 | — | 4,471,592 | $13.86M | Q4 2025 | Feb 17, 2026 |
| Fmr Llc | Buy | +4,237,590 | — | 4,237,590 | $13.14M | Q4 2025 | Feb 17, 2026 |
| Millennium Management Llc | Buy | +3,584,288 | — | 3,584,288 | $11.11M | Q4 2025 | Feb 17, 2026 |
| Two Sigma Investments, Lp | Buy | +3,397,110 | — | 3,397,110 | $10.53M | Q4 2025 | Feb 17, 2026 |
| Rock Springs Capital Management Lp | Buy | +3,266,960 | — | 3,266,960 | $10.13M | Q4 2025 | Feb 17, 2026 |
| Perceptive Advisors Llc | Buy | +3,139,669 | — | 3,139,669 | $9.73M | Q4 2025 | Feb 17, 2026 |
| Opaleye Management Inc. | Buy | +2,720,000 | — | 2,720,000 | $8.43M | Q4 2025 | Feb 17, 2026 |
| Two Sigma Advisers, Lp | Buy | +2,596,900 | — | 2,596,900 | $8.05M | Q4 2025 | Feb 17, 2026 |
| Bank Of America Corp | Buy | +1,906,669 | — | 1,906,669 | $5.91M | Q4 2025 | Feb 17, 2026 |
| Balyasny Asset Management L.P. | Buy | +1,516,691 | — | 1,516,691 | $4.70M | Q4 2025 | Feb 17, 2026 |
| Northern Trust Corp | Buy | +1,416,540 | — | 1,416,540 | $4.39M | Q4 2025 | Feb 17, 2026 |
| Aqr Capital Management Llc | Buy | +1,119,240 | — | 1,119,240 | $3.47M | Q4 2025 | Feb 17, 2026 |
| Integral Health Asset Management, Llc | Buy | +1,000,000 | — | 1,000,000 | $3.10M | Q4 2025 | Feb 17, 2026 |
| Citadel Advisors Llc | Buy | +704,787 | — | 704,787 | $2.18M | Q4 2025 | Feb 17, 2026 |
| Wellington Management Group Llp | Buy | +601,323 | — | 601,323 | $1.86M | Q4 2025 | Feb 17, 2026 |
| Qube Research & Technologies Ltd | Buy | +540,567 | — | 540,567 | $1.68M | Q4 2025 | Feb 17, 2026 |
| Silverback Asset Management Llc | Buy | +500,000 | — | 500,000 | $1.55M | Q4 2025 | Feb 17, 2026 |
Frequently asked questions about GOSS activity
Which institutional owners are buying GOSS?
Institutional owners buying GOSS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in GOSS activity?
"Buy" means an investor increased their reported position in GOSS compared to the prior reporting period. This reflects growing exposure to GOSSAMER BIO INC (GOSS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in GOSS increasing?
Institutional interest in GOSS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related GOSS Institutional Insights
- GOSS Overview
- GOSS 13F Institutional Holders
- GOSS Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- GOSS Insider Trading & SEC Form 4 Activity
- GOSS Articles
- Top Institutional Investor Stock Rankings